Apple Watch Series 11 receives FDA approval for hypertension alerts
Apple's new Apple Watch Series 11 has received FDA approval for its hypertension alert feature, which will be available in 150 countries when the watch and Apple Watch Ultra 3 ship starting on September 19. The feature uses the watch's optical heart sensor and a new machine learning algorithm to detect patterns associated with hypertension (high blood pressure) over a month-long period, providing users with a warning about potential danger. This feature is distinct from devices that measure specific blood pressure. Apple has previously received FDA approval for its over-the-counter Hearing Aid function and sleep apnea detection feature, but the company is currently facing a lawsuit over the redesigned blood oxygen monitoring feature in the Apple Watch.
Source: For the complete article, please visit the original source link below.
